Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.6 (
thromboplastin
)
13,278
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In order to study
arginine decarboxylase
regulation, we produced an antiserum against a hybrid of a 615 amino acid residue fragment of grapevine
arginine decarboxylase
cDNA with maltose-binding protein. The antiserum generated recognized mainly a protein band of ca. 80 kDa in extracts from grapevine tissues. Extracts from leaves and internodes in different developmental stages showed differences in the quantity of the 80 kDa band recognized by the antiserum. However, these differences did not correspond with changes in
arginine decarboxylase
specific activity. Furthermore, western blot analysis of extracts from cell cultures, where enzyme-specific activity was induced or repressed, did not reveal respective changes in the quantity of the 80 kDa protein band. Digestion of the hybrid by the specific protease
factor Xa
resulted in a polypeptide of 90 kDa instead of the expected two polypeptides of 43 and 66 kDa. Finally, western blot analysis of shoot extract incubated with
factor Xa
or the hybrid protein previously digested by
factor Xa
revealed that
factor Xa
-digested hybrid protein cleaved the 80 kDa band, resulting in two bands of ca. 38 and 40 kDa, whereas
factor Xa
alone did not affect it. These results suggest that
arginine decarboxylase
protein levels and/or activity is post-translationally regulated, as has been shown for other enzymes of polyamine biosynthesis.
...
PMID:Indications for post-translational regulation of Vitis vinifera L. arginine decarboxylase. 1143 Apr 29